Trump's return to the White House has introduced significant uncertainty for investors in the medical device industry. Major ...

President Donald Trump has swiftly announced a series of executive orders that could impact the medech industry.

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Johnson & Johnson (J&J) MedTech has reported a 4.8% growth in global sales in 2024, though it expects its 2025 outlook to ...

After its long-time chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has tapped Katie Szyman for the role, who served as head of Edwards' critical ...

Cantor Fitzgerald analyst Ross Osborn increased the 12-month price target on Sanara MedTech shares to $46 from $44, while maintaining an Overweight rating. The adjustment follows Sanara's announcement ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

OncoAssure's new data demonstrates that its biopsy test provides an 'improved estimation' of a patient’s risk of prostate ...

Corilus connects healthcare providers, patients and stakeholders via its cloud-based software and patient app.